Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer

The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition

Annals of Surgical Oncology ◽

10.1245/s10434-018-7068-3 ◽

2018 ◽

Vol 26 (5) ◽

pp. 1227-1235 ◽

Cited By ~ 9

Author(s):

Maoli Wang ◽

Kejin Wu ◽

Peng Zhang ◽

Mingdi Zhang ◽

Ang Ding ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Prognostic Significance ◽

Recurrence Score ◽

Oncotype Dx ◽

8Th Edition ◽

Proliferation (Ki-67 and Phosphohistone H3) and Oncotype DX Recurrence Score in Estrogen Receptor-positive Breast Cancer

Applied Immunohistochemistry & Molecular Morphology ◽

10.1097/pai.0b013e318206d23d ◽

2011 ◽

Vol 19 (5) ◽

pp. 431-436 ◽

Cited By ~ 38

Author(s):

Daron J. Williams ◽

Cynthia Cohen ◽

Mary Darrow ◽

Andrew J. Page ◽

Beth Chastain ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Ki 67 ◽

Phosphohistone H3 ◽

Oncotype Dx Recurrence Score ◽

Positive Breast Cancer

Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12779 ◽

2017 ◽

Vol 14 (2) ◽

pp. e161-e166 ◽

Cited By ~ 4

Author(s):

Aaron C. Tan ◽

Bob T. Li ◽

Kazi Nahar ◽

Suzanne Danieletto ◽

Eva S. Fong ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Prognostic Markers ◽

Recurrence Score ◽

Oncotype Dx ◽

Oncotype Dx Recurrence Score ◽

Positive Breast Cancer

Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results

SpringerPlus ◽

10.1186/2193-1801-3-71 ◽

2014 ◽

Vol 3 (1) ◽

Cited By ~ 15

Author(s):

Georgeta Fried ◽

Mor Moskovitz

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Early Breast Cancer ◽

Recurrence Score ◽

Treatment Decisions ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

The Effect of Oncotype DX Recurrence Score on Treatment Recommendations for Patients with Estrogen Receptor–Positive Early Stage Breast Cancer and Correlation with Estimation of Recurrence Risk by Breast Cancer Specialists

The Oncologist ◽

10.1634/theoncologist.2011-0045 ◽

2011 ◽

Vol 16 (11) ◽

pp. 1520-1526 ◽

Cited By ~ 65

Author(s):

Jennifer E. Joh ◽

Nicole N. Esposito ◽

John V. Kiluk ◽

Christine Laronga ◽

M. Catherine Lee ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Early Stage ◽

Recurrence Score ◽

Recurrence Risk ◽

Oncotype Dx ◽

Early Stage Breast Cancer ◽

Cancer Specialists ◽

Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution

The Breast ◽

10.1016/s0960-9776(17)30297-7 ◽

2017 ◽

Vol 32 ◽

pp. S92-S93

Author(s):

A. Gasol Cudos ◽

S. Morales Murillo ◽

M.J. Panades Siurana ◽

F. Vilardell Villellas ◽

C. Canosa Morales ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Recurrence Score ◽

Treatment Decisions ◽

Oncotype Dx ◽

Single Institution ◽

Node Positive ◽

P206 German multicentre decision impact study of Oncotype DX recurrence score (RS) on adjuvant treatment in estrogen receptor positive (ER+) node negative (N0) and node positive (N+) early breast cancer

The Breast ◽

10.1016/s0960-9776(11)70147-3 ◽

2011 ◽

Vol 20 ◽

pp. S46 ◽

Cited By ~ 3

Author(s):

J.-U. Blohmer ◽

T. Kühn ◽

M. Rezai ◽

S. Kümmel ◽

M. Warm ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Recurrence Score ◽

Oncotype Dx ◽

Impact Study ◽

Node Negative ◽

Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage breast cancer (ESBC) patients

The Breast ◽

10.1016/s0960-9776(19)30105-5 ◽

2019 ◽

Vol 44 ◽

pp. S16

Author(s):

K. Petrakova ◽

L. Petruzelka ◽

M. Holanek ◽

T. Svoboda ◽

V. Benesova ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Czech Republic ◽

Adjuvant Chemotherapy ◽

Early Stage ◽

Recurrence Score ◽

Oncotype Dx ◽

The Czech Republic ◽

Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor–Positive Breast Cancer: A Multicohort Study

Radiology ◽

10.1148/radiol.2021210738 ◽

2021 ◽

Author(s):

Ming Fan ◽

Yajing Cui ◽

Chao You ◽

Li Liu ◽

Yajia Gu ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Prediction Of Survival ◽

Oncotype Dx Recurrence Score ◽

Positive Breast Cancer

Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-009-0736-8 ◽

2009 ◽

Vol 136 (6) ◽

pp. 939-944 ◽

Cited By ~ 11

Author(s):

Kyoko Yorozuya ◽

Toru Takeuchi ◽

Miwa Yoshida ◽

Yukako Mouri ◽

Junko Kousaka ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Prognostic Factor ◽

Recurrence Score ◽

Oncotype Dx ◽

Stage I ◽

Primary Stage ◽

Node Negative ◽